On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

420 with CNW – Tobacco Giant Quietly Establishes Foothold in Marijuana Tech

Back in 2018, Tobacco giant Altria invested $1.8 billion in Canadian cannabis company Cronos Group. The very public investment gave Altria a 45% stake in the Canadian firm with an option to increase its stake to 55% over the next five years. Since then, the company, which is the parent firm for cigarette brands like Malboro and Parliament, has been trying to increase its stake in the nascent marijuana industry behind the scenes by patenting cannabis technology.

According to records from the United States Patent and Trademark Office, Altria filed two patents for vaporizer devices specifically designed for cannabis in late February this year. It also owns two older vaporizer patents from the same inventor filed before Altria bought a stake in Cronos and Cronos got those patents through a sale, a company spokesman said. Designed by Israel-based inventor Youseff Raichman, the vaporizers have temperature controls meant to allow customers to vaporize and dose THC or CBD.

At the moment, Altria hasn’t made great inroads into the American market, with its efforts being restricted to dabbling in the hemp and CBD markets. Still, the four cannabis-based patents the company has filed so far show that it is serious about investing in marijuana as a new growth area, especially as the sales of traditional cigarettes decline. However, like most firms in the cannabis space, Altria’s investment suffered during the pandemic, losing roughly one-third of its value.

Altria spokesman George Parman points out that although the device descriptions specifically mention cannabis, the company is attempting to patent them as plant “agnostic.” This means they could be used to vaporize other plants, such as loose-leaf tobacco. He adds that the devices will not be on the market any time soon, noting that the company did not submit the devices to the US Food and Drug Administration (“FDA”) before a September 9 deadline for “tobacco products.”

The patents for dosing THC and CBD can be extremely useful in the medical cannabis market and if they are awarded, could be quite lucrative for the firm, especially if cannabis is ever removed from Schedule I of the Controlled Substances Act and made available under a doctor’s prescription.

“It would make sense that Altria would seek patents for dosing and other medical applications as it would help them gain any regulatory approval where applicable in the future,” says Dominick Volpini, vice president of Cloudious 9, a California based company that makes vaporizers. “At some point in the future, the FDA will approve a cannabis vaporizer, after federal regulation changes, and most likely it will be a medically focused device with dosing capabilities.”

It would be interesting to get the views of cannabis industry players like Pure Extract Technologies Inc. regarding the strategic direction that Altria has chosen to take.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

Denver, Colorado
303.498.7722 Office

CNW420 is part of the InvestorBrandNetwork.


Select A Month

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo

CannabisNewsWire Currently Accepts



Bitcoin Cash

Bitcoin Cash

Doge Coin






USD Coin

USD Coin

Contact us: 303.498.7722